Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-37,612
Closed -$705K 363
2020
Q4
$705K Buy
+37,612
New +$613K 0.04% 168
2017
Q3
Sell
-5,943
Closed -$231K 246
2017
Q2
$231K Sell
5,943
-213
-3% -$8.17K 0.03% 206
2017
Q1
$240K Buy
6,156
+213
+4% +$8.59K 0.03% 210
2016
Q4
$227K Sell
5,943
-742
-11% -$27.6K 0.04% 206
2016
Q3
$255K Buy
6,685
+307
+5% +$13.6K 0.05% 188
2016
Q2
$276K Buy
6,378
+525
+9% +$23.2K 0.05% 191
2016
Q1
$271K Sell
5,853
-610
-9% -$29.4K 0.05% 177
2015
Q4
$349K Hold
6,463
0.07% 146
2015
Q3
$260K Sell
6,463
-5,115
-44% -$285K 0.06% 173
2015
Q2
$786K Hold
11,578
0.16% 103
2015
Q1
$687K Buy
11,578
+5,648
+95% +$322K 0.13% 107
2014
Q4
$334K Buy
+5,930
New +$318K 0.09% 101

Other funds holding VTRS

GW & Wade's VTRS Position: Q1 2021 in Review

GW & Wade sold out of Viatris (VTRS) in Q1 2021, closing a stake of 37,612 shares — an estimated $705K sold.

GW & Wade first reported a position in VTRS in Q4 2014 and held it in 12 quarters. The position peaked at $786K in Q2 2015. 1,115 funds tracked by Wall St. Rank hold VTRS as of Q1 2021.

  • GW & Wade reported no remaining Viatris position as of Q1 2021 after selling out during the quarter.
  • GW & Wade sold 37,612 Viatris shares in Q1 2021, an estimated $705K.
  • GW & Wade first reported a position in Viatris in Q4 2014 and held it in 12 quarters.
  • GW & Wade's Viatris position peaked at $786K in Q2 2015.
  • 1,115 funds tracked by Wall St. Rank held Viatris as of Q1 2021.

Based on GW & Wade's 13F filing for Q1 2021, filed 5 May 2021.